Two Sigma Investments’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
Other funds holding TARS
Two Sigma Investments's TARS Position: Q3 2026 in Review
Two Sigma Investments increased its Tarsus Pharmaceuticals (TARS) stake by 410% in Q3 2026, buying an estimated $10.3M and bringing the position to 183,665 shares worth $14.4M. The position accounts for 0.01% of the portfolio, ranked #1253.
Two Sigma Investments first reported a position in TARS in Q2 2022 and has held it in 16 quarters since. 255 funds tracked by Wall St. Rank hold TARS as of Q3 2026.
- Two Sigma Investments held 183,665 shares of Tarsus Pharmaceuticals worth $14.4M as of Q3 2026.
- Two Sigma Investments bought 147,627 Tarsus Pharmaceuticals shares in Q3 2026, an estimated $10.3M.
- Tarsus Pharmaceuticals made up 0.01% of Two Sigma Investments's portfolio in Q3 2026, its #1253 holding.
- Two Sigma Investments first reported a position in Tarsus Pharmaceuticals in Q2 2022 and has held it in 16 quarters since.
- 255 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q3 2026.
Based on Two Sigma Investments's 13F filing for Q3 2026, filed 16 Nov 2026.